The aim of this study was to present our experience with the management of bladder cancer (BCa) in individuals followed for neurogenic bladder (NB).
An Italian tertiary referral center for NB.
We retrospectively collected all pre-operative, intra-operative, and post-operative data of our NB cases with BCa, diagnosed from 2004 to 2019.
We included ten cases: eight with acquired spinal cord injury (SCI) and two with myelomeningocele (MMC). Considering individuals with acquired SCI, the median age at BCa diagnosis and time since SCI were 53 and 34 years, respectively. One out of seven cases had positive urine cytology. All cases underwent a radical cystectomy, diagnosing squamous cell carcinoma (SCC) and transitional cell carcinoma in 60 and 40% cases, respectively. Surgical-related complications occurred after 90% procedures. Three out of eight individuals with acquired SCI died 2, 12, and 80 months after the diagnosis. Both individuals with MMC presented no evidence of disease after 24 and 27 months.
BCa in individuals with NB proved to be associated with a diagnosis at an advanced stage and a high rate of surgical complications. In this population we advocate annual genitourinary ultrasound exam and urine cytology, and cystoscopy in all cases of macrohematuria. Considering the low accuracy of urine cytology and the difficult-to-interpret inflamed bladder walls at cystoscopy in NB, a patient-tailored follow-up schedule based on specific risk factors (e.g., smoking status, indwelling urinary catheter) is mandatory to diagnose and treat BCa at an early stage.
Subscribe to Journal
Get full journal access for 1 year
We are sorry, but there is no personal subscription option available for your country.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.
Freedman N, Silverman D, Hollenbeck A, Schatzkin A, Abnet C. Association between smoking and risk of bladder cancer among men and women. JAMA. 2011;306:737–45.
Burger M, Catto J, Dalbagni G, Grossman H, Herr H, Karakiewicz P, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63:234–41.
Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C. Mechanisms of disease: the epidemiology of bladder cancer. Nat Clin Pr Urol. 2006;3:327–40.
Ginsberg D. The epidemiology and pathophysiology of neurogenic bladder. Am J Manage Care. 2013;19:s191–6.
El Masriy WS, Patil S, Prasanna KV, Chowdhury JR. To cystoscope or not to cystoscope patients with traumatic spinal cord injuries managed with indwelling urethral or suprapubic catheters? That is the question! Spinal Cord. 2014;52:49–53.
Ismail S, Karsenty G, Chartier-Kastler E, Cussenot O, Compérat E, Rouprêt M, et al. Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: a systematic review. Neurourol Urodyn. 2018;37:1386–95.
Stillman MD, Hoffman JM, Barber JK, Williams SR, Burns SP. Urinary tract infections and bladder management over the first year after discharge from inpatient rehabilitation. Spinal Cord Ser Cases. 2018;4:92.
Mirkin K, Casey JT, Mukherjee S, Kielb SJ. Risk of bladder cancer in patients with spina bifida: Case reports and review of the literature. J Pediatr Rehabil Med. 2013;6:155–62.
Gui-Zhong L, Li-Bo M. Bladder cancer in individuals with spinal cord injuries: a meta-analysis. Spinal Cord. 2017;55:341–45.
Averbeck MA, Madersbacher H. Follow-up of the neuro-urological patient: a systematic review. BJU Int. 2015;115:39–46.
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications. Ann Surg. 2009;250:187–96.
Eisenhauer E, Therasse P, Bogaerts J, Schwartz L, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47.
Böthig R, Kurze I, Fiebag K, Kaufmann A, Schöps W, Kadhum T, et al. Clinical characteristics of bladder cancer in patients with spinal cord injury: the experience from a single centre. Int Urol Nephrol. 2017;49:983–94.
Böthig R, Hirschfeld S, Thietje R. Quality of life and urological morbidity in tetraplegics with artificial ventilation managed with suprapubic or intermittent catheterisation. Spinal Cord. 2012;50:247–51.
Parra J, Drouin S, Comperat E, Misraï V, Van Glabeke E, Richard F, et al. Bladder cancer in neurological patients: analysis of a single-centre series. Prog Urol. 2007;17:1333–6.
Prattley S, New F, Davies M. Malignancies of suprapubic catheter (SPC) tracts in spinal cord injury patients: a case series and review of literature. Spinal Cord Ser Cases. 2019;5:34.
Lee WY, Sun LM, Lin CL, Liang JA, Chang YJ, Sung FC, et al. Risk of prostate and bladder cancers in patients with spinal cord injury: a population-based cohort study. Urol Oncol Semin Orig Investig. 2014;32:51.e1–7.
Sun Y, Tang C, Bai Y, Li N, Yang L, Wei Q, et al. Urethral diverticular with broadly squamous metaplasia in a patient with urethral diverticular calculi. Medicine. 2019;98:e16923.
Ali P, Lefevrec C, Perrouin-Verbec B, Le Normand L, Rigaud J, Bouchotd O, et al. Bladder cancer in neurogenic patients: a retrospective study of management and follow-up. Progrès en Urol. 2017;28:215–20.
Manach Q, Cussenot O, Rouprêt M, Gamé X, Chartier-Kastler E, Reus C, et al. Analysis of bladder cancer subtypes in neurogenic bladder tumors. Can J Urol. 2018;25:9161–67.
Kalisvaart JF, Katsumi HK, Ronningen LD, Hovey RM. Bladder cancer in spinal cord injury patients. Spinal Cord. 2010;48:257–61.
Böthig R, Fiebag K, Kowald B, Hirschfeld S, Thietje R, Kurze I, et al. Spinal cord injury with neurogenic lower urinary tract dysfunction as a potential risk factor for bladder carcinoma. Aktuelle Urol. 2019;50:280–91.
Fitzpatrick R, Baverstock R. Muscle invasive bladder cancer presenting as recurrent autonomic dysreflexia—a wolf in wolf’s clothing. J Spinal Cord Med. 2018;20:1–4.
Davis M. When guidelines conflict: patient safety, quality of life, and CAUTI reduction in patients with spinal cord injury. Spinal Cord Ser Cases. 2019;5:56.
Cheng JN, Lawrentschuk N, Gyomber D, Rogerson J, Bolton DM. Cystectomy in patients with spinal cord injury: indications and long-term outcomes. J Urol. 2010;184:92–8.
Nahm LS, Chen Y, Devivo MJ, Lloyd LK. Bladder cancer mortality after spinal cord injury over 4 decades. J Urol. 2015;193:1923–8.
Elliott SP. Screening for bladder cancer in individuals with spinal cord injury. J Urol. 2015;193:1880–1.
Alimi Q, Hascoet J, Manunta A, Kammerer-Jacquet SF, Verhoest G, Brochard C, et al. Reliability of urinary cytology and cystoscopy for the screening and diagnosis of bladder cancer in patients with neurogenic bladder: a systematic review. Neurourol Urodyn. 2018;37:916–25.
Schubert T, Rausch S, Fahmy O, Gakis G, Stenzl A. Optical improvements in the diagnosis of bladder cancer: implications for clinical practice. Ther Adv Urol. 2017;9:251–60.
Chen C, Hao H, Tianxin L, Jian H. Diagnostic accuracy of image technique based transurethral resection for non-muscle invasive bladder cancer. Eur Urol Suppl. 2019;18:e1956.
Przydacz M, Chlosta P, Corcos J. Recommendations for urological follow-up of patients with neurogenic bladder secondary to spinal cord injury. Int Urol Nephrol. 2018;50:1005–16.
Cameron AP, Rodriguez GM, Schomer KG. Systematic review of urological followup after spinal cord injury. J Urol. 2012;187:391–7.
Biering-Sørensen F, Kennelly M, Kessler TM, Linsenmeyer T, Pannek J, Vogel L, et al. International spinal cord injury lower urinary tract function basic data set (version 2.0). Spinal Cord Ser Cases. 2018;4:60.
McColl MA, Gupta S, Smith K, McColl A. Promoting long-term health among people with spinal cord injury: What’s new? Int J Environ Res Public Health. 2017;14:1520.
Sammer U, Walter M, Knüpfer SC, Mehnert U, Bode-Lesniewska B, Kessler TM. Do we need surveillance urethro-cystoscopy in patients with neurogenic lower urinary tract dysfunction? PLoS ONE. 2015;10:e0140970.
Maurice M, Meeks J, Smith N. Orthotopic neobladder for bladder cancer and neurogenic bladder dysfunction. Can J Urol. 2008;15:4194–5.
James A, Lin D, Wright J. Neobladders and continent catheterizable stomas for the bladder cancer survivor. Curr Opin Urol. 2014;24:407–14.
Novara G, Catto JWF, Wilson T, Annerstedt M, Chan K, Murphy DG, et al. Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy. Eur Urol. 2015;67:376–401.
Yates CC, Garrison MK, Charlesworth A, Reese NB, Garcia-Rill E. Therapeutic approaches for spinal cord injury induced spasticity. Transl Neurosci. 2010;1:160–69.
Auerbach M, Macdougall I. The available intravenous iron formulations: history, efficacy, and toxicology. Hemodial Int. 2017;21:S83–S92.
Nygren J, Thacker J, Carli F, Fearon KCH, Norderval S, Lobo DN, et al. Guidelines for perioperative care in elective rectal/pelvic surgery: enhanced recovery after surgery (ERAS®) society recommendations. World J Surg. 2013;37:285–305.
Burns P, Rohrich R, Chong K. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg. 2011;128:305–10.
Hollingsworth J, Rogers M, Krein S, Hickner A, Kuhn L, Cheng A, et al. Determining the noninfectious complications of indwelling urethral catheters. Ann Intern Med. 2013;159:401–10.
Qu L, Lawrentschuk N. Bladder cancer surveillance in patients with spinal cord injuries. BJU Int. 2019;123:379–80.
Conflict of interest
The authors declare that they have no conflict of interest.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Sampogna, G., Maltagliati, M., Galfano, A. et al. Experience of a tertiary referral center in managing bladder cancer in conjunction with neurogenic bladder. Spinal Cord Ser Cases 6, 61 (2020). https://doi.org/10.1038/s41394-020-0302-9